Advertisement
Advertisement
U.S. Markets close in 3 hrs 23 mins
Advertisement
Advertisement
Advertisement
Advertisement

Psychemedics Corporation (PMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.48+0.04 (+0.62%)
As of 10:03AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.44
Open6.58
Bid6.28 x 900
Ask6.40 x 1000
Day's Range6.45 - 6.58
52 Week Range6.01 - 8.90
Volume516
Avg. Volume16,253
Market Cap35.914M
Beta (5Y Monthly)0.77
PE Ratio (TTM)90.00
EPS (TTM)0.07
Earnings DateMar 21, 2022 - Mar 25, 2022
Forward Dividend & Yield0.20 (2.74%)
Ex-Dividend DateDec 17, 2021
1y Target EstN/A
  • GlobeNewswire

    Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend

    ACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2022, and the declaration of a cash dividend of $0.07 per share to be paid on June 24, 2022, to shareholders of record as of May 27, 2022. The Company’s revenue for the quarter ended March 31, 2022, was $6.5 million versus $5.7 million for the quarter ended March 31, 2021, an

  • Simply Wall St.

    Peter Kamin of Psychemedics Corporation (NASDAQ:PMD) Just Spent US$112k On Shares

    Investors who take an interest in Psychemedics Corporation ( NASDAQ:PMD ) should definitely note that insider Peter...

  • GlobeNewswire

    Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

    ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2021. The Company’s revenue for the year ended December 31, 2021, was $24.9 million versus $21.4 million for the year ended December 31, 2020, an increase of 17%. Net loss for the year ended December 31, 2021, was $0.7 million or $0.12 per diluted s

Advertisement
Advertisement